Tech Company Financing Transactions

Neuroglee Therapeutics Funding Round

On 9/10/2021, Neuroglee Therapeutics raised $10 million in Series A funding from Edbi, Openspace Ventures and Eisai.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

2 Venture Dr. Vision Exchange 15-32
Singapore, 608526
Singapore

Phone

Undisclosed

Website

www.neuroglee.com

Email Address

[email protected]

Overview

We harness the power of software to build evidence-based, precision digital therapeutics for neurodegenerative diseases. By combining best-in-class cognitive rehabilitation strategies and machine learning approaches, our digital therapeutic and monitoring tools empower patients, families and clinicians by helping to preserve cognition and independence.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Aniket Rajput

        

Chief Scientific Officer

Michael Patterson

        

Browse more venture capital transactions:

Prev: 9/10/2021: Evolve Additive Solutions venture capital transaction
Next: 9/10/2021: Snyk venture capital transaction

Share this article

News on VC Transactions

We do our best to document funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary